Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
EXEL - LONG-TERM DEBT
Long-term Debt EXEL - Exelixis, Inc.
190 M
LAST VALUE
92.47%
2 YEAR CAGR
73.22%
5 YEAR CAGR
-5.53%
10 YEAR CAGR